Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Korean J Hematol. 2012 Sep;47(3):225-228. English. Case Report. https://doi.org/10.5045/kjh.2012.47.3.225
Jeong JH , Ahn JY , Park SH , Park MJ , Kim KH , Hong JS .
Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, Korea. jyahn@gilhospital.com
Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Abstract

Radioiodine is regularly used in the treatment of thyroid cancer to eliminate residual malignant tissue after thyroidectomy and to treat metastasis. Because of the low dose of radioiodine used to treat thyroid cancer patients, leukemia is an uncommon complication of exposure to radioiodine. Here, we present a patient who developed therapy-related acute myeloid leukemia with inv(16)(p13.1q22);CBFbeta-MYH11, eosinophilia, and K-ras mutation and who had been treated with very low-dose radioiodine following total thyroidectomy.

Copyright © 2019. Korean Association of Medical Journal Editors.